Discard the vial
In addition, some researchers have used immunotherapy and synthetic biology to design living bacteria, combining immunotherapy expression with optimized lysis mechanism, so that living bacteria can carry nanobodies back to the core of necrotic tumors, grow to a critical density, and lyse, effectively and continuously releasing therapeutic drugs in the tumor microenvironment
if a calculated dose falls below 10 units, consider a smaller-capacity syringe for improved accuracy
It is not a scheduled compound in the United States and carries RUO (research-use-only) classification
RESEARCH-GRADE ADVANCED NASAL SPRAY SOLUTIONS CellGenic offers premium nasal spray formulations developed to support innovative research in peptide delivery, cognitive health, cellular function, and regenerative medicine
That said, several important safety considerations remain: No FDA approval : BPC-157 is not approved by the U.S